U-Systems' somo•v

Courtesy of U-Systems

Sunnyvale, CA's U-Systems had a whirlwind 2012. In April, it won a huge FDA panel backing for its somo•v Automated Breast Ultrasound device. In September, it won a PMA for the system, and then, in November, it got snapped up by megaconglomerate GE ($GE) for an undisclosed sum.

First, the device: somo•v is designed to detect smaller tumors in dense breast tissue, which can lead to challenges in traditional mammography as denser breasts have more connective and glandular tissues that can obscure smaller tumors and delay cancer detection.

It's the first imaging system indicated for dense breasts, and somo•v is meant to be paired with mammograms. In clinical studies, radiologists compared mammography alone to the procedure plus somo•v on 200 dense-breasted women with initially negative results, finding that U-Systems' technology led to more precise diagnoses.

And that goes a ways in explaining why GE Healthcare was allured. GE is a heavyweight in the imaging world, and now it can add somo•v to its stable of digital mammography and magnetic resonance devices.

U-Systems' somo•v